(Q39568906)

13 September 2017

title

Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90917

16 April 2022

1 reference

drug-induced lupus erythematosus

1 reference

H. G. Bluestein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90917

16 April 2022

N. J. Zvaifler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90917

16 April 2022

M. H. Weisman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90917

16 April 2022

R. F. Shapiro

4

0 references

language of work or name

English

0 references

1 October 1979

1 reference

13 September 2017

20 October 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=90917

full work available at URL

16 April 2022

https://api.elsevier.com/content/article/PII:S0140673679921743?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

https://api.elsevier.com/content/article/PII:S0140673679921743?httpAccept=text/plain

16 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

16 April 2022

1 reference

13 September 2017

volume

2

1 reference

13 September 2017

issue

8147

1 reference

13 September 2017

page(s)

816-819

1 reference

Antinuclear antibody induced by procainamide. A prospective study

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Procainamide-induced serologic changes in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Drug-induced systemic lupus erythematosus: A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Lymphocytotoxic antibody activity in cryoprecipitates from serum of patients with SLE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Anti-DNA antibody in procainmide-induced lupus erythematosus. Determination using DNA fractionated by methylated albumin-kieselguhr chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Antibodies to Histones in Drug-Induced and Idiopathic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Drugs which affect the Structure and Function of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

The interaction of lupus-inducing drugs with deoxyribonucleic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Procainamide-induced lupus erythematosus. Clinical and laboratory observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Hypocomplementemia in Procainamide-Associated Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Inhibition of surface capping of macromolecules by local anaesthetics and tranquillisers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

A serum inhibitor of immune regulation in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992174-3

7 January 2021

Transplantation reviews

4

31

240

Disordered immunologic regulation and autoimmunity (English)

author name string

Talal

1976

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

16 April 2022

Federation Proceedings

7

33

1894

Drug-induced autoimmune disease (English)

author name string

Tan

1974

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

16 April 2022

16

44

664

Drug-induced lupus syndromes (English)

author name string

Alarcon-Segovia

1969

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

Disordered immunologic regulation and autoimmunity

16 April 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

Drug-induced autoimmune disease

17 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

Drug-induced lupus syndromes

17 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

Effects of psychoactive drugs on in vitro lymphocyte activation

17 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92174-3

17 November 2022

Identifiers

1 reference

13 September 2017

1 reference